|
π
|
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
23 auth.
R. Banchereau,
Seunghee Hong,
Brandi Cantarel,
Nicole E. Baldwin,
J. Baisch,
M. Edens,
A. Cepika,
P. AΜcs,
J. Turner,
E. Anguiano,
...
P. Vinod,
Shaheen Khan,
G. Obermoser,
D. Blankenship,
E. Wakeland,
L. Nassi,
A. Gotte,
M. Punaro,
Yongβjun Liu,
J. Banchereau,
J. RossellΓ³-Urgell,
Tracey Wright,
V. Pascual
|
9 |
2016 |
9
π
|
|
π¦
|
Autoimmunity, Checkpoint Inhibitor Therapy and Immune-related Adverse Events: A Review.
Shaheen Khan,
D. Gerber
|
7 |
2020 |
7
π¦
|
|
π
|
Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
9 auth.
Sung-Dae Cho,
K. Yoon,
Sudhakar Chintharlapalli,
M. Abdelrahim,
P. Lei,
S. Hamilton,
...
Shaheen Khan,
S. Ramaiah,
S. Safe
|
7 |
2007 |
7
π
|
|
π
|
3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.
12 auth.
M. Abdelrahim,
E. Ariazi,
Kyounghyun Kim,
Shaheen Khan,
R. Barhoumi,
R. Burghardt,
...
Shengxi Liu,
Denise S. Hill,
R. Finnell,
B. Wlodarczyk,
V. Jordan,
S. Safe
|
7 |
2006 |
7
π
|
|
π¦
|
Immune dysregulation in cancer patients developing immune-related adverse events
11 auth.
Shaheen Khan,
S. Khan,
Xin Luo,
Farjana J Fattah,
Jessica M. Saltarski,
Yvonne Gloria-McCutchen,
...
Rong Lu,
Yang Xie,
Quanzhen Li,
E. Wakeland,
D. Gerber
|
7 |
2018 |
7
π¦
|
|
π
|
Beclin 2 Functions in Autophagy, Degradation of G Protein-Coupled Receptors, and Metabolism
17 auth.
Congcong He,
Yongjie Wei,
Kai Sun,
Binghua Li,
Xiaonan Dong,
Z. Zou,
Yang Liu,
L. Kinch,
Shaheen Khan,
Sangita C. Sinha,
...
R. Xavier,
N. Grishin,
Guanghua Xiao,
E. Eskelinen,
P. Scherer,
Jennifer L. Whistler,
B. Levine
|
7 |
2013 |
7
π
|
|
π
|
Melanoma models for the next generation of therapies.
36 auth.
E. Patton,
Kristen L. Mueller,
D. Adams,
N. Anandasabapathy,
A. Aplin,
C. Bertolotto,
M. Bosenberg,
C. Ceol,
Christin E. Burd,
Ping Chi,
M. Herlyn,
S. Holmen,
F. Karreth,
C. Kaufman,
Shaheen Khan,
...
S. Kobold,
E. Leucci,
Carmit Levy,
D. Lombard,
A. Lund,
Kerrie L. Marie,
J. Marine,
R. Marais,
M. McMahon,
C. D. Robles-Espinoza,
Z. Ronai,
Yardena Samuels,
M. Soengas,
J. Villanueva,
A. Weeraratna,
R. White,
I. Yeh,
Jiyue Zhu,
L. Zon,
M. Hurlbert,
G. Merlino
|
6 |
2021 |
6
π
|
|
π
|
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
23 auth.
R. Banchereau,
Seunghee Hong,
Brandi Cantarel,
Nicole E. Baldwin,
J. Baisch,
M. Edens,
A. Cepika,
P. AΜcs,
J. Turner,
E. Anguiano,
...
P. Vinod,
Shaheen Khan,
G. Obermoser,
D. Blankenship,
E. Wakeland,
L. Nassi,
A. Gotte,
M. Punaro,
Yongβjun Liu,
J. Banchereau,
J. RossellΓ³-Urgell,
Tracey Wright,
V. Pascual
|
6 |
2016 |
6
π
|
|
π
|
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
29 auth.
P. Raj,
E. Rai,
R. Song,
Shaheen Khan,
B. Wakeland,
K. Viswanathan,
C. Arana,
C. Liang,
Bo Zhang,
I. Dozmorov,
Ferdicia Carr-Johnson,
M. MitroviΔ,
G. Wiley,
J. Kelly,
B. Lauwerys,
...
N. Olsen,
C. Cotsapas,
C. Garcia,
C. Wise,
J. Harley,
S. Nath,
J. James,
C. Jacob,
B. Tsao,
C. Pasare,
D. Karp,
Quanzhen Li,
P. Gaffney,
E. Wakeland
|
6 |
2016 |
6
π
|
|
π¬
|
Targeting NR4A1 (TR3) in cancer cells and tumors
Syng-Ook Lee,
Xi Li,
Shaheen Khan,
S. Safe
|
6 |
2011 |
6
π¬
|
